View in EDS

Formulation-Specific Cardiovascular Outcomes with High-Dose Eicosapentaenoic Acid: A Systematic Review and Meta-analysis.

Saved in:
Bibliographic Details
Title: Formulation-Specific Cardiovascular Outcomes with High-Dose Eicosapentaenoic Acid: A Systematic Review and Meta-analysis.
Authors: Faheem MA; Department of Medicine, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan., Azeem B; Department of Medicine, Shaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, Pakistan., Ali T; Department of Medicine, Shaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, Pakistan. talhaali190@gmail.com., Asim R; Department of Medicine, Shaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, Pakistan., Muhammad TS; Department of Medicine, Shaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, Pakistan., Dogar ME; Department of Medicine, Shaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, Pakistan., Naveed MA; Department of Medicine, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.
Source: American journal of cardiovascular drugs : drugs, devices, and other interventions [Am J Cardiovasc Drugs] 2026 Jul; Vol. 26 (4), pp. 453-465. Date of Electronic Publication: 2026 May 02.
Publication Type: Journal Article; Systematic Review; Meta-Analysis
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100967755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-187X (Electronic) Linking ISSN: 11753277 NLM ISO Abbreviation: Am J Cardiovasc Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42070013
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Formulation-Specific Cardiovascular Outcomes with High-Dose Eicosapentaenoic Acid: A Systematic Review and Meta-analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Faheem+MA%22">Faheem MA</searchLink>; Department of Medicine, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.<br /><searchLink fieldCode="AU" term="%22Azeem+B%22">Azeem B</searchLink>; Department of Medicine, Shaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, Pakistan.<br /><searchLink fieldCode="AU" term="%22Ali+T%22">Ali T</searchLink>; Department of Medicine, Shaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, Pakistan. talhaali190@gmail.com.<br /><searchLink fieldCode="AU" term="%22Asim+R%22">Asim R</searchLink>; Department of Medicine, Shaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, Pakistan.<br /><searchLink fieldCode="AU" term="%22Muhammad+TS%22">Muhammad TS</searchLink>; Department of Medicine, Shaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, Pakistan.<br /><searchLink fieldCode="AU" term="%22Dogar+ME%22">Dogar ME</searchLink>; Department of Medicine, Shaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, Pakistan.<br /><searchLink fieldCode="AU" term="%22Naveed+MA%22">Naveed MA</searchLink>; Department of Medicine, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100967755%22">American journal of cardiovascular drugs : drugs, devices, and other interventions</searchLink> [Am J Cardiovasc Drugs] 2026 Jul; Vol. 26 (4), pp. 453-465. <i>Date of Electronic Publication: </i>2026 May 02.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Systematic Review; Meta-Analysis
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>100967755 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-187X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211753277%22">11753277 </searchLink><i>NLM ISO Abbreviation: </i>Am J Cardiovasc Drugs <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42070013
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40256-026-00798-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 453
    Titles:
      – TitleFull: Formulation-Specific Cardiovascular Outcomes with High-Dose Eicosapentaenoic Acid: A Systematic Review and Meta-analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Faheem MA
      – PersonEntity:
          Name:
            NameFull: Azeem B
      – PersonEntity:
          Name:
            NameFull: Ali T
      – PersonEntity:
          Name:
            NameFull: Asim R
      – PersonEntity:
          Name:
            NameFull: Muhammad TS
      – PersonEntity:
          Name:
            NameFull: Dogar ME
      – PersonEntity:
          Name:
            NameFull: Naveed MA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2026 Jul
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1179-187X
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: American journal of cardiovascular drugs : drugs, devices, and other interventions
              Type: main
ResultId 1